WEST LAFAYETTE, Ind., May 31, 2012 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT - News), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that Ron Ellis, president and CEO of Endocyte, will present at the upcoming Jefferies 2012 Global Healthcare Conference on Thursday, June 7, at 12:30 p.m. EDT. The conference is being held in New York.
